Project Grant R01CA296071
Award Date 9/12/25
Completion Date 8/31/29
Dollars Obligated $2.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
- This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...
- The Project Grant award of $403,822, awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research), will fund a pilot study to develop and test the "DESCANSO" cognitive behavioral therapy (CBT) intervention to treat the symptom cluster of depression, insomnia, and fatigue in Spanish-speaking Latino cancer patients. The study aims to culturally adapt the DESCANSO intervention, which combines CBT strategies to address insomnia, depression, and...
- This $3,355,681 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) aims to evaluate the impact of accessible and scalable digital interventions to address co-occurring insomnia and depression in breast cancer survivors. The project will assess the efficacy of two evidence-based digital interventions, SHUTI and INTELLICARE, in treating these conditions both individually and through an adaptive approach that sequences the interventions based...
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES" to address clinically significant levels of depression, pain, and fatigue experienced by over 18 million Americans living with cancer. The project aims to...
- The National Cancer Institute (NCI) awarded a $414,446 Project Grant to Colorado State University (CSU) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to conduct a 12-week group-based videoconference intervention aimed at increasing moderate to vigorous physical activity (MVPA) among cancer survivors. The goal is to examine the efficacy of this virtual exercise intervention in improving physical function, quality of life, and other health outcomes for this population....
- The U.S. Department of Health and Human Services, National Institutes of Health (NIH) awarded a $406,080 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The purpose of this 5-year grant, awarded on April 1, 2025, is to develop and test a novel daily, digital mindfulness-based intervention to reduce depressive symptoms in post-treatment cancer patients. The project will first create the...
- This $658,743 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Kaiser Foundation Hospitals aims to develop and validate prediction models for trajectories of function, cognition, and quality of life among adults aged 65 and older with advanced non-small cell lung cancer during up to 6 months of chemotherapy and/or immunotherapy. The 5-year project builds on an ongoing observational cohort study of 130 older adults with advanced lung...
- This $431,970 federal Project Grant awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) aims to develop a culturally-adapted, behavioral intervention called "South Asian Family Approaches to Disease (SAFAD)" to support self-management and alleviate stress, loneliness, and social isolation among South Asian breast cancer survivors and their family caregivers. The grant recipient, The Leland Stanford Junior University, will pursue two specific...
- This federal Project Grant award of $386,612 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a research project by the Regents of the University of Minnesota to investigate socioeconomic and environmental factors that contribute to accelerated biological aging, cancer risk, and differences in cancer outcomes among middle-aged and older adults. The project will leverage data from two large prospective studies, the Atherosclerosis Risk in...
- This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...